Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Fusidic acid for Sale > Diosmin, Barosmin/grey-brown powder/capillary permeability reduction, venous tone, microcirculation, anti-inflammatory
Diosmin, Barosmin/grey-brown powder/capillary permeability reduction, venous tone, microcirculation, anti-inflammatory buy - large image1
Diosmin, Barosmin/grey-brown powder/capillary permeability reduction, venous tone, microcirculation, anti-inflammatory buy - image1
Diosmin, Barosmin/grey-brown powder/capillary permeability reduction, venous tone, microcirculation, anti-inflammatory buy - image2
Diosmin, Barosmin/grey-brown powder/capillary permeability reduction, venous tone, microcirculation, anti-inflammatory buy - image3
Diosmin, Barosmin/grey-brown powder/capillary permeability reduction, venous tone, microcirculation, anti-inflammatory buy - image4
Diosmin, Barosmin/grey-brown powder/capillary permeability reduction, venous tone, microcirculation, anti-inflammatory buy - image5
Diosmin, Barosmin/grey-brown powder/capillary permeability reduction, venous tone, microcirculation, anti-inflammatory buy - image6

Diosmin, Barosmin/grey-brown powder/capillary permeability reduction, venous tone, microcirculation, anti-inflammatory

7 Inquiries

Unit Price:

$100-130/G FOB

Get Latest Price
CAS No.:

6990-06-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

qingdao

Brand:

sinov

Packaging:

vial/box

Price valid (until):

2026-10-28

Company Type:
Trader
Location:
Hongkong, China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
7 days
Qualification:
Main Products:

Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Description

    This product is Fusidic Acid (also known as Fusidine), CAS No. 6990-06-3, a steroidal antibiotic extracted and refined from microbial fermentation broth. Its molecular formula is C₃₁H₄₈O₆ with a molecular weight of approximately 516.71. It normally appears as white to off-white crystalline powder, with purity reaching over 98% (tested by HPLC). Pharmaceutical grade products comply with pharmacopoeia standards such as USP and EP. As a mature commercial pharmaceutical raw material, this product is available in different grades including pharmaceutical grade and reagent grade according to application requirements. It is mainly supplied to pharmaceutical enterprises, formulation manufacturers and scientific research institutions, and is one of the widely circulated antibiotic varieties in the global market. The product shall be stored in a sealed container, protected from light, and kept in a cool and dry place.

    Key Effects

    Fusidic acid is a highly targeted and clinically well-established antibiotic. It mainly acts against Gram-positive bacteria, a large group of common bacteria that cause skin and soft tissue infections, including clinically challenging resistant staphylococci. Fusidic acid inhibits infection by interfering with bacterial protein synthesis and stopping bacterial reproduction. Owing to its definite therapeutic effect and low irritation for topical and ocular infections, it has long been formulated into ointments, creams, eye drops and other preparations. Widely used in dermatology and ophthalmology, it serves as an important anti-infective pharmaceutical ingredient.

    Its specific functions can be summarized as follows:
    Inhibit bacterial reproduction: Interfere with bacterial protein synthesis and block the growth and reproduction of pathogenic bacteria;
    Anti-Gram-positive bacteria: Show good activity against common pathogenic bacteria such as staphylococci, including some resistant strains;
    Treat skin infections: For topical treatment of superficial infections including acne, folliculitis and infected skin ulcers;
    Treat ocular infections: Used as a raw material for preparations against bacterial eye infections such as conjunctivitis;
    Systemic infection treatment: Clinically applied to treat severe infections in sites such as bones and joints;
    Role as a research tool: Used as an antibiotic reference standard and research tool for studies on microorganisms and drug resistance.

    Applications

    This product is a pharmaceutical API, mainly targeting the production and research & development of anti-infective pharmaceutical preparations. It serves as an important raw material for anti-infective medications in dermatology and ophthalmology.
    Its main application areas are summarized as follows:
    Topical dermatological preparations: Used for the production of skin anti-infective preparations such as fusidic acid ointments and creams;
    Ophthalmic preparations: Used for the production of ocular anti-infective preparations including fusidic acid eye drops;
    Systemic anti-infective drugs: As an API, applied in the manufacture of oral or injectable anti-infective medicines;
    Pharmaceutical research and development: Used as antibiotic reference standards, control substances, and tool materials for drug resistance research;
    Export trade and raw material supply: Supplied as a pharmaceutical raw material to pharmaceutical factories, preparation manufacturers and traders, with specifications available upon customer request.

    Shop Diosmin, Barosmin/grey-brown powder/capillary permeability reduction, venous tone, microcirculation, anti-inflammatory-Detailed Image 1 Shop Diosmin, Barosmin/grey-brown powder/capillary permeability reduction, venous tone, microcirculation, anti-inflammatory-Detailed Image 2 Shop Diosmin, Barosmin/grey-brown powder/capillary permeability reduction, venous tone, microcirculation, anti-inflammatory-Detailed Image 3 Shop Diosmin, Barosmin/grey-brown powder/capillary permeability reduction, venous tone, microcirculation, anti-inflammatory-Detailed Image 4 Shop Diosmin, Barosmin/grey-brown powder/capillary permeability reduction, venous tone, microcirculation, anti-inflammatory-Detailed Image 5


    Items Specifications
    Fusidic Acid 10mg
    Fusidic Acid 1g
    Fusidic Acid 1kg
    ECHEMI Editorial Reference
    Fusidic acid (Fusidate) is a bacteriostatic antibiotic[1][2][3].

    Basic Info
    Product Name:

    Fusidic acid

    Other Name:

    29-Nordammara-17(20),24-dien-21-oic acid,16-(acetyloxy)-3,11-dihydroxy-,(3α,4α,8α,9β,11α,13α,14β,16β,17Z)-;29-Nor-8α,9β,13α,14β-dammara-17(20),24-dien-21-oic acid,3α,11α,16β-trihydroxy-,16-acetate,(Z)-;Fusidic acid;(3α,4α,8α,9β,11α,13α,14β,16β,17Z)-16-(Acetyloxy)-3,11-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid;Ramycin;SQ 16603;Fucithalmic;Fusidinic acid;NSC 56192;Flucidin;Foban;Fugen;Optifucin;Phudicin;Usidin;62-60-2;1386-65-8;1404-47-3;2618-21-5;313340-66-8

    CAS No.:

    6990-06-3

    Molecular Formula:

    C31H48O6

    InChIKeys:

    InChIKey=IECPWNUMDGFDKC-MZJAQBGESA-N

    Molecular Weight:

    516.71

    Exact Mass:

    516.71

    EC Number:

    230-256-0

    HScode:

    29419000

    Characteristics
    PSA:

    104

    XLogP3:

    5.5

    Appearance:

    Solid

    Density:

    1.2±0.1 g/cm3

    Melting Point:

    192.5 °C

    Boiling Point:

    635.6±55.0 °C at 760 mmHg

    Flash Point:

    197.7±25.0 °C

    Refractive Index:

    1.558

    Water Solubility:

    5.21e-03 g/L

    Storage Conditions:

    2-8°C

    Toxicity:

    LD50 in mice (g/kg): 1.2 s.c.; 1.5 orally (Godtfredsen)

    Specific rotation:

    D20 -9° (chloroform)

    PKA:

    5.35None

    Hazard Identification

    Classification of the substance or mixture

    Acute toxicity - Category 4, Oral

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H302 Harmful if swallowed

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    Response

    P301+P317 IF SWALLOWED: Get medical help.

    P330 Rinse mouth.

    Storage

    none

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

    Location:

    Unit D01,3/F., Wong King Industrial Building,No.2 Tai Yau Street, Kowloon

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7 days

    Total Annual Revenue:

    $50 million-$100 million

    Total Employees:

    51-100

    Year of Establishment:

    2012

    We have more than 10 years experience in the pharmacy filed. Mainly manufactures pharmaceutical APIs,Pharmaceutical intermediate and Cosmetic raw material. Owing to the good quality and competitive price, we have a very good reputation in China's pharmaceutical circles.

    In the principle of "Quality Oriented", Jianfeng passed the certification of ISO9001:2008 Quality Management System.

    Our products are based on bulk, high volume, wholesale price, third party testing, certificate reporting, and bring high quality ingredients to many domestic and overseas enterprises.

    "Honesty, practicality, innovation, development" are our values. Jianfeng would like to cooperate with you with high quality products and competitive price.

  • Inquiry History
    7 Inquiries
    Country Product Purchase Quantity Date Posted
    Turkey

    Fusidic acid CAS No.: 6990-06-3

    100 KG Feb 28, 2026
    India

    Fusidic Acid

    500 KG Feb 24, 2026
    Pakistan

    FUSIDIC ACID

    10 KG May 12, 2025
    Yemen

    Fusidic acid

    1 MT Apr 2, 2025
    Russia

    fusidic acid

    100 G Sep 18, 2024
    Pakistan

    Fusidic acid

    10 KG Sep 18, 2026
    Guatemala

    fusidic acid

    1 MT Jul 18, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.